Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PeerJ ; 8: e8230, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31938575

RESUMO

BACKGROUND: Ammonium (NH4 +) and nitrate (NO3 -) are two inorganic forms of nitrogen (N) that are deposited from the atmosphere into soil systems. As the substrate and product of soil nitrification, these two forms of inorganic nitrogen will affect or be affected by the soil net nitrification rate (Nr). Our knowledge regarding soil nitrification is mainly derived from studies with bulk soil. However, soil is composed of different aggregate fractions, which may have an important impact on Nr. METHODS: In 2017, we collected soil samples from an alpine meadow of the Qinghai-Tibet Plateau and separated them into four soil aggregates (2-4, 1-2, 0.25-1, and <0.25 mm) using the dry sieving method. The four soil aggregate sizes amended with the 2 N deposition forms (NH4 +-N and NO3 --N) were then incubated at 25 °C for 28 days, and the soil aggregates for each treatment were collected on day 0, 7, 14, 21, and 28 to determine the NO3 --N concentration. The soil Nr and contribution of soil aggregates to the nitrification rate in the bulk soil were calculated. RESULTS: There were differences in the physicochemical properties of the soil aggregates. The addition of N and aggregate size had strong effects on soil Nr, which were significantly increased under high levels of NH4 + addition across all soil aggregates. The Nr during the 4 week incubation period differed among aggregate sizes. Nr in the 2-4 mm aggregates was higher than in the other aggregates, which was correlated with the maximum values of the soil porosity observed in the 2-4 mm aggregates. Furthermore, almost half of the soil was composed of aggregates of <0.25 mm, indicating that the <0.25 mm aggregates made a higher contribution to the nitrification rate in the bulk soil than the other aggregates, even though these aggregates had a lower nitrification ability. Overall, our study revealed that the soil nitrification rate was influenced by both the N addition and soil aggregates, and that the 2-4 mm aggregates had a dominant effect on the response of soil N transformation processes to future nitrogen deposition in the alpine meadow.

2.
Theriogenology ; 107: 85-94, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29132039

RESUMO

Gonadotropins and growth factors synergistically regulate folliculogenesis and oocyte development. C-X-C motif chemokine 12 (CXCL12) and its receptor CXCR4 are expressed in ovaries of sheep, cattle and other species, however, roles of this multifunctional signal axis in oocyte maturation are not defined. Using sheep as a model, we examined the expression patterns and functions of the CXCL12-CXCR4 axis during oocyte maturation. CXCL12 and CXCR4 mRNA and protein were present in oocytes and granulosa cells. Relative abundance of CXCR4 transcript was controlled by epidermal growth factor (EGF). Transient inhibition of CXCR4 suppressed oocyte nuclear maturation while supplementing recombination CXCL12 significantly increased percent of oocyte undergone metaphase I phase. Inhibition of CXCR4 function decreased cumulus expansion growth rate. Furthermore, granulosa cell migration was impaired and expression of hyaluronan synthase 2 (HAS2) and hyaluronan binding protein tumor necrosis factor-alpha-induced protein 6 (TNFAIP6) were downregulated by CXCR4 inhibition. These findings revealed a novel role of the CXCL12-CXCR4 signaling in oocyte development in sheep.


Assuntos
Quimiocina CXCL12/metabolismo , Células do Cúmulo/fisiologia , Oócitos/fisiologia , Receptores CXCR4/metabolismo , Ovinos , Animais , Moléculas de Adesão Celular/genética , Moléculas de Adesão Celular/metabolismo , Quimiocina CXCL12/genética , Feminino , Regulação da Expressão Gênica , Células da Granulosa/fisiologia , Hialuronan Sintases/genética , Hialuronan Sintases/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores CXCR4/genética , Transdução de Sinais/fisiologia
3.
Sci Total Environ ; 592: 565-572, 2017 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-28318700

RESUMO

Increases in nitrogen (N) deposition along with climate warming can change the dynamics of carbon and nitrogen in the soil, and alter greenhouse gases (GHGs) fluxes. To examine how N deposition and warming affect GHGs (CH4, CO2 and N2O) fluxes in alpine grasslands, we conducted experiments in an alpine meadow (AM), alpine-steppe (AS), and alpine cultivated grassland (CG) on the Qinghai-Tibetan Plateau (QTP). We simulated N deposition by treating soil with ammonium nitrate (NH4NO3) (8kgNha-1year-1), a warming treatment using an open top chamber (OTC) was carried out, and a combined treatment of warming and N deposition (8kgNha-1year-1) was conducted. The GHGs were collected during early, peak, and late plant growing seasons, i.e., May, August, and October of 2015, respectively, using a static chamber. We found, in general, neither N deposition nor warming solely altered CH4 and N2O fluxes in the alpine grasslands. The N deposition under warming conditions reduced CO2 emission significantly. The reduction of CO2 emission was most significant in the alpine steppe. The effects of climatic warming and N deposition on the GHGs varied greatly across the grassland types and the growing seasons. The cultivated grasslands were much more unstable than the native grasslands in CH4 uptake. In can be concluded the N deposition associated with human activities may buffer the CO2 emission in the alpine grassland ecosystems in terms of climate changes on the QTP.

4.
PLoS One ; 11(2): e0149461, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26894743

RESUMO

UNLABELLED: The objective of this study was to investigate the effects of growth hormone-releasing peptide-2 (GHRP-2) and cysteamine (CS) administration on growth performance in yaks with growth retardation and try to elucidate its regulatory mechanisms. Trial 1, thirty-six 1-year-old Qinghai high plateau yaks (body weight 38-83.2 kg) were randomly chosen for body weight and jugular blood samples collection. The relationship between body weight and serum GHRH (P < 0.05, R = 0.45), GH (P < 0.05, R = 0.47), IGF-1 (P < 0.05, R = 0.62) was significantly correlated in yaks colonies with lighter body weights. Trial 2, fifteen 1-year-old Qinghai high plateau yaks with growth retardation (average body weight 54.8 ± 8.24 kg) were randomly selected and assigned to negative control group (NG), GHRP-2 injection group (GG) and cysteamine feeding group (CG), with 5 yaks per group. Another five 1-year-old Qinghai high plateau yaks with normal growth performance (average body weight 75.3 ± 2.43 kg) were selected as positive control group (PG). The average daily gain (ADG) of the GG and CG were significantly higher than those in the PG and NG (P < 0.05). Both GHRP-2 and CS administration significantly enhanced the myofiber diameter and area of skeletal muscle (P<0.05). GHRP-2 significantly enhanced the serum GH and IGF-1 levels (P < 0.05), and up-regulated GHR, IGF-1 and IGF-1R mRNA expression in the liver and skeletal muscle (P < 0.05), enhanced the mRNA expression of PI3K, AKt and mTOR in the skeletal muscle (P<0.05). CS significantly reduced the serum SS levels and the hypothalamus SS mRNA expression (P < 0.05), and enhanced GHR and IGF-1 mRNA expression in the liver (P < 0.05), decreased the mRNA expression of muscle atrophy F-box (Atrogin-1) and muscle ring finger 1 (MuRF1) mRNA (P < 0.05). CONCLUSIONS: Growth retardation in yaks was primarily due to somatotropic axis hormones secretion deficiency. Both GHRP-2 and CS administration can accelerate growth performance and GH, IGF-1 secretion in yaks with growth retardation. GHRP-2 enhanced muscle protein deposition mainly by up-regulated the protein synthesis pathways, whereas CS worked mainly by down-regulated the ubiquitin-proteasome pathway.


Assuntos
Bovinos/crescimento & desenvolvimento , Cisteamina/farmacologia , Transtornos do Crescimento/veterinária , Fator de Crescimento Insulin-Like I/metabolismo , Músculo Esquelético/efeitos dos fármacos , Oligopeptídeos/farmacologia , Animais , Peso Corporal/efeitos dos fármacos , Feminino , Transtornos do Crescimento/tratamento farmacológico , Hormônio do Crescimento/sangue , Hormônio Liberador de Hormônio do Crescimento/sangue , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Somatostatina/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA